COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,252 Articles (22,733 medRxiv, 8,519 bioRxiv)

Most recent first Previous |  Page 681: Articles 6801-6810  | Next

SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta
van Doremalen, N., Singh, M., Saturday, T., Yinda, K. C., Perez-Perez, L., Bohler, W. F., Weishampel, Z., Lewis, M., Schulz, J., Williamson, B., Meade-White, K., Gallogly, S., Okumura, A., Feldmann, F., Lovaglio, J., Hanley, P., Shaia, C., Feldmann, H., de Wit, E., Munster, V., Rosenke, K.
10.1101/2022.08.01.502390 — Posted: 2022-08-02
Does Influenza vaccination reduce the risk of contracting COVID-19?
Alos, F., Canovas-Zaldua, Y., Feijoo, M. V., del val, J. L., Sanchez-Callejas, A., Colomer, M. A.
10.1101/2022.08.01.22278264 — Posted: 2022-08-02
The speed of vaccination rollout and the risk of pathogen adaptation
Gandon, S., Day, T., Lambert, A.
10.1101/2022.08.01.22278283 — Posted: 2022-08-02
Complex Temporal Behaviour Modeling for Pandemic Spread: Not a Simple Delayed Response!
Shahtori, N., Atashzar, S. F.
10.1101/2022.08.01.22278281 — Posted: 2022-08-02
Intermediate levels of asymptomatic transmission can lead to the highest levels of epidemic fatalities
Park, S. W., Dushoff, J., Grenfell, B., Weitz, J. S.
10.1101/2022.08.01.22278288 — Posted: 2022-08-02
Viral and Symptom Rebound in Untreated COVID-19 Infection
Deo, R., Choudhary, M. C., Moser, C., Ritz, J., Daar, E. S., Wohl, D. A., Greninger, A. L., Eron, J. J., Currier, J. S., Hughes, M. D., Smith, D. M., Chew, K. W., Li, J. Z.
10.1101/2022.08.01.22278278 — Posted: 2022-08-02
Development, testing and validation of a SARS-CoV-2 multiplex panel for detection of the five major variants of concern on a portable PCR platform
Stanhope, B. J., Peterson, B., Knight, B., Decadiz, R., Pan, R., Davis, P., Fraser, A., Nuth, M., vanWestrienen, J., Wendlandt, E., Goodwin, B. G., Myers, C., Stone, J. J., Sozhamannan, S.
10.1101/2022.08.02.22277351 — Posted: 2022-08-02
An integrated epidemiologic and economic model to assess optimal COVID-19 pandemic policy
Szanyi, J., Wilson, T., Howe, S., Zeng, J., Andrabi, H., Blakely, T.
10.1101/2022.08.01.22278262 — Posted: 2022-08-02
Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England
The OpenSAFELY Collaborative, , Nab, L., Parker, E. P. K., Andrews, C. D., Hulme, W. J., Fisher, L., Morley, J., Mehrkar, A., MacKenna, B., Inglesby, P., Morton, C. E., Bacon, S. C., Hickman, G., Evans, D., Ward, T., Smith, R. M., Davy, S., Dillingham, I., Maude, S., Butler-Cole, B. F., O'Dwyer, T., Stables, C. L., Bridges, L., Bates, C., Cockburn, J., Parry, J., Hester, F., Harper, S., Zheng, B., Williamson, E. J., Eggo, R. M., Evans, S. J., Goldacre, B., Tomlinson, L. A., Walker, A. J.
10.1101/2022.07.30.22278161 — Posted: 2022-08-02
Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome
Lewnard, J. A., Hong, V., Tartof, S. Y.
10.1101/2022.07.31.22278258 — Posted: 2022-08-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).